Noven Pharmaceuticals Inc - Corporate and Strategic Assessment Report – Company Strategy, SWOT Analysis - www.companiesandmarkets.com adds new report

2008-07-17 10:43:17 - Noven Pharmaceuticals Inc - Corporate and Strategic Assessment Report – Company Strategy, SWOT Analysis - a new market research report on www.companiesandmarkets.com

www.companiesandmarkets.com/Summary-Company-Profile/Noven-Pharma ..

Introduction

Noven Pharmaceuticals (Noven) is a specialty pharmaceutical company engaged in the discovery, development, manufacture and commercialization of prescription pharmaceutical products. The company markets a portfolio of hormone therapy products including Vivelle Dot, CombiPatch and Daytrana developed using its proprietary transdermal drug delivery technology, DOT Matrix.



Scope

Contains corporate strategy, value chain presence and SWOT Analysis
Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors
Includes information on suppliers/ partners, shareholding structure and key employees with biographies


Highlights

Noven is focused on the development of transdermal drug delivery technology and prescription transdermal products. Vivelle Dot, CombiPatch and Daytrana are the company´s lead transdermal products. The company has a pipeline of drugs which it develops through its collaborators and licensees.



The company´s total revenues increased at a CAGR of 2% during 2002-2006, from $55 million to $61 million mainly due to revenues recognized under product sales, contract fees, royalty and milestone payments from licensees including Novartis, Novogyne, Shire, and Aventis.



Noven´s revenues are forecast to have an absolute growth of +$108 million with revenues of $61 million in 2006 increasing to $169 million in 2010 primarily due to product sales of Daytrana, Vivelle Dot, Pexeva and Stavzor and the license fees and other revenues earned in connection with the it´s collaborations with Novartis, Shire and Novogyne.



Reasons to Purchase

Access all the important information and analysis on the company in a single report
Understand company´s strengths, weaknesses, opportunities and threats along with business strategy and value chain
Gain access to company´s adjusted five year financial data along with key ratios and market capitalization


www.companiesandmarkets.com/Summary-Company-Profile/Noven-Pharma ..